NCT07105384View on ClinicalTrials.gov

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

June 20, 2028

Study Completion Date

December 20, 2028

Conditions
Parkinson Disease
Interventions
COMBINATION_PRODUCT

Radiotracer

Patients will receive a brain tau radiotracer

Trial Locations (1)

08036

Laura Burunat, Barcelona

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT07105384 - Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy | Biotech Hunter | Biotech Hunter